Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials

Find Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Near You

Physiologic Effects of Nasal High Flow on Exercise Tolerance in Chronic Obstructive Pulmonary Disease (COPD)

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study aims to assess whether to describe the effects of the administration of nasal high flow (NHF) at 70 liters per minute (L/min) in a 6-Minute Walk Test (6-MWT) among Chronic Obstructive Pulmonary Disease (COPD) patients and to characterize the association between self-reported dyspnea with and without NHF at 70 L/min following a 6-MWT.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 100
Healthy Volunteers: f
View:

• Able to consent

• Age 18 years or older

• Diagnosis of COPD

• Ability to ambulate without assistance

• Use of low-flow nasal cannula ≤ 4 L/min or no supplemental oxygen (O2) at all

Locations
United States
Florida
University of Miami
RECRUITING
Miami
Contact Information
Primary
Saramaria Afanador Castiblanco, M.D.
saramaria.afanador@miami.edu
305-243-2568
Time Frame
Start Date: 2024-12-12
Estimated Completion Date: 2027-12-31
Participants
Target number of participants: 30
Treatments
Experimental: Nasal High Flow Cannula
Nasal High Flow cannula at 70 liters per minute for 30 minutes. Given that this is a cross-over study, participants on this arm will be then crossed over to Nasal Low Flow Cannula at less than or equal to 4 liters per minute with supplemental oxygen for 30 minutes
Active_comparator: Nasal Low Flow Cannula
Low Flow Nasal Cannula at less than or equal to 4 liters per minute with supplemental oxygen at patient's baseline for 30 minutes. Given that this is a cross-over study, participants on this arm will be then crossed over to High Flow Cannula at 70 liters per minute for 30 minutes
Sponsors
Collaborators: American Thoracic Society
Leads: University of Miami

This content was sourced from clinicaltrials.gov